Quick Update for all of you who are wondering about and/or interested in the followup regarding the FDA’s approval of Humira.
Back in August (link to original story-here) you may remember we talked about the approval process that the Food and Drug Administration was taking regarding Abbott Laboratories anti-tumor necrosis factor (TNF) medications that blocks proteins that play an important role in abnormal inflammatory and immune responses. Well, just yesterday, they made a public announcement about their decision to move forward with medication being approved for moderate to severe ulcerative colitis patients as a potential treatment. Obviously this is a huge win for Abbott Laboratories, and you can read the direct news release from the FDA website here if you like:
Also, there is a category setup on this website with stories related to Humira if you are interested in learning more about UC’ers experiences, that link is right here: https://ihaveuc.com/category/ulcerative-colitis-drugs/humira/
Back during the August FDA Gastro meeting, where Humira was being reviewed, there was a request for the manufacturer to supply some more clinical trial information, and I’m assuming that Abbott has finally satisfied the FDA with that request which prompted their press release yesterday.
Alrightee, talk to you all soon,